Sign In
Buy AWH
$0.0820
+0 (+0%)
At Close: Jul 30, 2025
Aspira Women's Health Inc. Appoints Nicole Sandford to its Board of Directors
08:30am, Monday, 22'nd Feb 2021
AUSTIN, Texas, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced the appointment of Ms. Nicole Sandford to its B
AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health, Inc. (Nasdaq: AWH), a bioanalytical-based women's health company, today announced management will participate and present in the
Aspira Women's Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX™ Clinical Report
05:38pm, Wednesday, 10'th Feb 2021
Aspira will incorporate Management Recommendations from the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in the Aspira GenetiX report A
Aspira Women's Health Inc. Announces Pricing of $45 Million Public Offering of Common Stock
09:25am, Thursday, 04'th Feb 2021
AUSTIN, Texas, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women's health company focused on gynecologic disease, today announced
Aspira Women's Health Inc. Announces Proposed Public Offering of Common Stock
04:03pm, Wednesday, 03'rd Feb 2021
AUSTIN, Texas, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women's health company focused on gynecologic disease, today announced
Aspira Women's Health, Inc. to Participate in Virtual Investor Events
04:34pm, Monday, 04'th Jan 2021
Aspira to participate in the 10 th Annual LifeSci Advisors Corporate Access Event and Biotech Showcase™ from January 6 – 15 th , 2021
Reviewing Aspira Women's Health (AWH) & Its Competitors
02:50am, Thursday, 22'nd Oct 2020
Aspira Women's Health (NASDAQ: AWH) is one of 34 public companies in the “Diagnostic substances” industry, but how does it contrast to its competitors? We will compare Aspira Women's Health to rel
COVID-19 Recovery Analysis: Spa Market | Growing Wellness Tourism Industry to Boost the Market Growth | Technavio
12:00am, Wednesday, 21'st Oct 2020
The Global Spa Market will grow by $ 25.48 bn during 2020-2024
UPDATE – Aspira Women’s Health Reports Second Quarter 2020 Financial Results
07:51pm, Friday, 14'th Aug 2020
Conference Call scheduled for today, August 13th at 4:30 p.m. ETAUSTIN, Texas, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“ASPIRA”) (Nasdaq: AWH), a bio-analytical based wome
Aspira Women's Health, Inc. (AWH) CEO Valerie Palmieri on Q2 2020 Results - Earnings Call Transcript
10:58pm, Thursday, 13'th Aug 2020
Aspira Women's Health, Inc. (NASDAQ:AWH) Q2 2020 Earnings Conference Call August 13, 2020, 16:30 ET Company Participants Valerie Palmieri - CEO, President & Director Lesley Northrop - Global Medic
Aspira Women’s Health Reports Second Quarter 2020 Financial Results
08:01pm, Thursday, 13'th Aug 2020
Conference Call scheduled for today, August 13th at 4:30 p.m. ETAUSTIN, Texas, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“ASPIRA”) (Nasdaq: AWH), a bio-analytical based wome
Aspira Women’s Health, Inc. to Report Second Quarter 2020 Financial Results on August 13th
01:23pm, Friday, 31'st Jul 2020
AUSTIN, Texas, July 31, 2020 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it will report financial results for the s
Insider Buying: Jack Schuler Just Spent US$8.0m On Aspira Women's Health Inc. (NASDAQ:AWH) Shares
10:30am, Wednesday, 08'th Jul 2020
Those following along with Aspira Women's Health Inc. (NASDAQ:AWH) will no doubt be intrigued by the recent purchase...
Aspira Women’s Health Inc. Announces Equity Financing of Approximately $11 Million
03:23pm, Wednesday, 01'st Jul 2020
The closing of the private placement is expected to occur on July 6, 2020, subject to customary closing conditions. At the closing, ASPIRA will receive approximately $11 million in gross proceeds, be
Aspira Women’s Health, Inc. Announces First Patient Enrolled in Prospective OVANex Study for Benign Pelvic Mass Monitoring
12:00pm, Monday, 29'th Jun 2020
Aspira Women’s Health, Inc. (AWH), a bioanalytical-based women’s health company, today announced the first patient enrolled in a national clinical study of benign pelvic mass management. The stud
